Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Clinical trial NCT06649331 · RECRUITING

Trial details

NCT number: NCT06649331
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Metastatic Breast Cancer Triple Negative Breast Cancer (TNBC)HER2-negative Breast Cancer Breast Cancer

Start date: 2024-10-21
Primary completion: 2026-09-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.